Open AccessDrug-induced cutaneous lupus erythematosus: 88 new cases
Author(s) -
Rasa Laurinaviciene,
Linda Holm Sandholdt,
Anette Bygum
Publication year - 2017
Publication title -
european journal of dermatology/ejd. european journal of dermatology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.48
H-Index - 71
eISSN - 1952-4013
pISSN - 1167-1122
DOI - 10.1684/ejd.2016.2912
Subject(s) - medicine , subacute cutaneous lupus erythematosus , dermatology , rash , serology , drug , malar rash , erythema , anti nuclear antibody , connective tissue disease , immunology , antibody , autoantibody , autoimmune disease , pharmacology , disease
An increasing number of drugs have been linked to drug-induced subacute cutaneous lupus erythematosus (DI-SCLE). The recognition and management of DI-SCLE can be challenging, as the condition may be triggered by different classes of drugs after variable lengths of time.